A phase Ib/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients.George A. Fisher, Amita Patnaik, Jens-Peter Volkmer et al.|Journal of Clinical Oncology|2020Cited by 53